Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H10O5 |
Molecular Weight | 270.2369 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=CC=C(C=C1)C2=CC(=O)C3=C(O)C=C(O)C=C3O2
InChI
InChIKey=KZNIFHPLKGYRTM-UHFFFAOYSA-N
InChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-7,16-18H
Molecular Formula | C15H10O5 |
Molecular Weight | 270.2369 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:08:17 UTC 2023
by
admin
on
Fri Dec 15 18:08:17 UTC 2023
|
Record UNII |
7V515PI7F6
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DSLD |
222 (Number of products:60)
Created by
admin on Fri Dec 15 18:08:18 UTC 2023 , Edited by admin on Fri Dec 15 18:08:18 UTC 2023
|
||
|
DSLD |
1394 (Number of products:104)
Created by
admin on Fri Dec 15 18:08:18 UTC 2023 , Edited by admin on Fri Dec 15 18:08:18 UTC 2023
|
||
|
NCI_THESAURUS |
C68464
Created by
admin on Fri Dec 15 18:08:18 UTC 2023 , Edited by admin on Fri Dec 15 18:08:18 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m1987
Created by
admin on Fri Dec 15 18:08:18 UTC 2023 , Edited by admin on Fri Dec 15 18:08:18 UTC 2023
|
PRIMARY | Merck Index | ||
|
1040683
Created by
admin on Fri Dec 15 18:08:18 UTC 2023 , Edited by admin on Fri Dec 15 18:08:18 UTC 2023
|
PRIMARY | |||
|
7573
Created by
admin on Fri Dec 15 18:08:18 UTC 2023 , Edited by admin on Fri Dec 15 18:08:18 UTC 2023
|
PRIMARY | |||
|
208-292-3
Created by
admin on Fri Dec 15 18:08:18 UTC 2023 , Edited by admin on Fri Dec 15 18:08:18 UTC 2023
|
PRIMARY | |||
|
D047310
Created by
admin on Fri Dec 15 18:08:18 UTC 2023 , Edited by admin on Fri Dec 15 18:08:18 UTC 2023
|
PRIMARY | |||
|
100000183496
Created by
admin on Fri Dec 15 18:08:18 UTC 2023 , Edited by admin on Fri Dec 15 18:08:18 UTC 2023
|
PRIMARY | |||
|
520-36-5
Created by
admin on Fri Dec 15 18:08:18 UTC 2023 , Edited by admin on Fri Dec 15 18:08:18 UTC 2023
|
PRIMARY | |||
|
7V515PI7F6
Created by
admin on Fri Dec 15 18:08:18 UTC 2023 , Edited by admin on Fri Dec 15 18:08:18 UTC 2023
|
PRIMARY | |||
|
83244
Created by
admin on Fri Dec 15 18:08:18 UTC 2023 , Edited by admin on Fri Dec 15 18:08:18 UTC 2023
|
PRIMARY | |||
|
DB07352
Created by
admin on Fri Dec 15 18:08:18 UTC 2023 , Edited by admin on Fri Dec 15 18:08:18 UTC 2023
|
PRIMARY | |||
|
APIGENIN
Created by
admin on Fri Dec 15 18:08:18 UTC 2023 , Edited by admin on Fri Dec 15 18:08:18 UTC 2023
|
PRIMARY | |||
|
5280443
Created by
admin on Fri Dec 15 18:08:18 UTC 2023 , Edited by admin on Fri Dec 15 18:08:18 UTC 2023
|
PRIMARY | |||
|
7V515PI7F6
Created by
admin on Fri Dec 15 18:08:18 UTC 2023 , Edited by admin on Fri Dec 15 18:08:18 UTC 2023
|
PRIMARY | |||
|
DTXSID6022391
Created by
admin on Fri Dec 15 18:08:18 UTC 2023 , Edited by admin on Fri Dec 15 18:08:18 UTC 2023
|
PRIMARY | |||
|
1368130
Created by
admin on Fri Dec 15 18:08:18 UTC 2023 , Edited by admin on Fri Dec 15 18:08:18 UTC 2023
|
PRIMARY | RxNorm | ||
|
18388
Created by
admin on Fri Dec 15 18:08:18 UTC 2023 , Edited by admin on Fri Dec 15 18:08:18 UTC 2023
|
PRIMARY | |||
|
C68466
Created by
admin on Fri Dec 15 18:08:18 UTC 2023 , Edited by admin on Fri Dec 15 18:08:18 UTC 2023
|
PRIMARY | |||
|
58470
Created by
admin on Fri Dec 15 18:08:18 UTC 2023 , Edited by admin on Fri Dec 15 18:08:18 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
1,1-Diphenyl-2-picrylhydrazyl radical scavenging assay(DPPH) IC50 expressed as ug/mL was not tested due to the limited samples available. In vitro hydroxyl radical scavenging assay(Hydroxy Radical) IC50 expressed as ug/mL >5.
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
53% Cell growth rate of human acute promyelocytic leukemia HL-60 cells at 50 uM of compound vs control
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |